Medical Irradiation Market Report 2026

Medical Irradiation Market Overview

• Medical Irradiation market size has reached to $1.96 billion in 2025 • Expected to grow to $3.77 billion in 2030 at a compound annual growth rate (CAGR) of 13.9% • Growth Driver: The Role Of Medical Irradiation In Addressing The Rising Prevalence Of Cancer Worldwide • Market Trend: Innovative Advancements In Medical Irradiation • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Medical Irradiation Market?

Medical irradiation refers to the targeted use of radiation in treating diseases, particularly cancer, where controlled doses are applied to damage or destroy specific cells while minimizing their impact on healthy tissues. It is employed in diagnostic settings to produce images of internal structures or functions, facilitating the identification and diagnosis of various medical conditions. The disease types of medical irradiation include trisomy 21, translocation medical irradiation, and mosaic medical irradiation. Trisomy 21 is a genetic condition characterized by the presence of an extra copy of chromosome 21, leading to Down syndrome. The treatment types are categorized into two categories such as diagnosis and therapy. The distribution channels include direct tenders, retail sales, and others. The end users are hospitals, clinics, homecare settings, therapy centers, and others.

What Is The Medical Irradiation Market Growth Forecast?

The medical irradiation market size is expected to see rapid growth in the next few years. It will grow to $3.77 billion in 2030 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to rising demand for precision cancer treatments, increasing awareness of early disease diagnosis, expansion of specialized therapy centers, growing geriatric population, continuous improvements in radiation safety standards. Major trends in the forecast period include rising adoption of targeted radiation therapies, growing use of irradiation in diagnostic imaging, increased focus on precision and dose optimization, expansion of radiation-based cancer treatment programs, higher emphasis on patient safety and regulatory compliance.

Global Medical Irradiation Market Segmentation

1) By Disease Type: Trisomy 21, Translocation Medical Irradiation, Mosaic Medical Irradiation 2) By Treatment: Diagnosis, Therapy 3) By Distribution Channel: Direct Tender, Retail Sales, Other Distribution Channels 4) By End User: Hospital, Clinics, Homecare Setting, Therapy Centers, Other End-Users Subsegments: 1) By Trisomy 21: Prenatal Diagnosis, Postnatal Diagnosis 2) By Translocation Medical Irradiation: Acute Lymphoblastic Leukemia (ALL), Chronic Myeloid Leukemia (CML) 3) By Mosaic Medical Irradiation: Genetic Counseling, Diagnostic Imaging

What Is The Driver Of The Medical Irradiation Market?

The high prevalence of cancer is expected to propel the growth of the medical irradiation market going forward. Cancer refers to the condition of uncontrolled cell growth, which impacts various organs and contributes to significant morbidity and mortality worldwide. Medical irradiation is a crucial tool in cancer treatment, utilizing targeted radiation to damage or destroy cancer cells while minimizing the impact on healthy tissues. For instance, according to a report published by the Leukemia & Lymphoma Society, a US-based non-profit health organization, in 2023, in the US, 184,720 persons are anticipated to receive a leukemia, lymphoma, or myeloma diagnosis in 2023. A projected 1,958,310 new cancer cases are expected to be diagnosed in the US in 2023, with new instances of leukemia, lymphoma, and myeloma likely to represent 9.4% of those cases. Therefore, the high prevalence of cancer is driving the growth of the medical irradiation industry.

Key Players In The Global Medical Irradiation Market

Major companies operating in the medical irradiation market are Hitachi Ltd., Toshiba Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., GE Healthcare Company, Mayo Clinic Health System, Canon Medical Systems R&D (Dalian) Co. Ltd., Varian Medical Systems Inc., Elekta AB, Accuray Incorporated, Ion Beam Applications S.A., Brainlab AG, ViewRay Technologies Inc., Mevion Medical Systems Inc., RaySearch Laboratories AB, NTP Radioisotopes SOC Ltd., RefleXion Medical Inc., Vision RT Ltd., Sun Nuclear Corporation, Eckert & Ziegler BEBIG GmbH, C-RAD AB, Panacea Medical Technologies Pvt. Ltd., Standard Imaging Inc., CIVCO Radiotherapy Inc., IntraOp Medical Corporation, RTsafe Solutions Ltd., Mirada Medical Corporation

Global Medical Irradiation Market Trends and Insights

Major companies operating in the medical irradiation market are developing innovative solutions, such as the Premium Dual-Energy Mobile System, to gain a competitive advantage. A Premium Dual-Energy Mobile System is a high-end medical imaging device that integrates dual-energy technology for enhanced diagnostic capabilities while offering mobility across different clinical settings, providing advanced imaging solutions at the point of care. For instance, in July 2023, KA Imaging, a Canada-based manufacturer, unveiled its Reveal Mobi Pro dual-energy mobile X-ray system. The Reveal Mobi Pro is a comprehensive mobile X-ray solution that combines SpectralDR technology with KA Imaging's Reveal 35C detector. At the bedside, Reveal's capacity to take dual-energy and conventional images simultaneously with a single exposure enhances patient and hospital results while safeguarding income by lowering outflows.

What Are Latest Mergers And Acquisitions In The Medical Irradiation Market?

In March 2024, AstraZeneca plc, a UK-based pharmaceutical company, acquired Fusion Pharmaceuticals Inc., for an undisclosed amount. With this acquisition, AstraZeneca aims to strengthen its oncology pipeline and expand targeted radiopharmaceutical capabilities by integrating Fusion Pharmaceuticals’ expertise in precision cancer therapies. Fusion Pharmaceuticals Inc. is a Canada-based biotechnology company that specializes in developing targeted radiopharmaceutical therapies for oncology applications.

Regional Outlook

North America was the largest region in the medical irradiation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Medical Irradiation Market?

The medical irradiation market includes revenues earned by entities by providing services such as diagnostic imaging services, radiation therapy, radiopharmaceutical and radiation safety, and dosimetry services. The market value includes the value of related goods sold by the service provider or included within the service offering. The medical irradiation market consists of sales of products such as radiation therapy equipment, diagnostic imaging devices, radiopharmaceuticals, and nuclear medicine devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Medical Irradiation Market Report 2026?

The medical irradiation market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the medical irradiation industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.